Pfizer Inc. Races to Reinvent Itself, Hunts for Mid-size Drug Deals

For years, drug companies have known that their days of plenty were numbered, that the moment would arrive when the best-selling drugs that had driven two decades worth of profits would lose their pat…
Read the full story: BioSpace.com Featured News